Business Description
NightHawk Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US42237K4094
Description
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | -0.65 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -10.33 | |||||
| Beneish M-Score | 0.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.4 | |||||
| 3-Year EBITDA Growth Rate | 5.3 | |||||
| 3-Year EPS without NRI Growth Rate | -1.2 | |||||
| 3-Year FCF Growth Rate | 2.7 | |||||
| 3-Year Book Growth Rate | -38.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.62 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.47 | |||||
| Days Inventory | 62.05 | |||||
| Days Sales Outstanding | 19.97 | |||||
| Days Payable | 347.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -1720.21 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.92 | |||||
| Operating Margin % | -311.73 | |||||
| Net Margin % | -286.89 | |||||
| FCF Margin % | -225.25 | |||||
| ROE % | -95.65 | |||||
| ROA % | -54.43 | |||||
| ROIC % | -59.28 | |||||
| ROC (Joel Greenblatt) % | -71.57 | |||||
| ROCE % | -76.54 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.04 | |||||
| Price-to-Tangible-Book | 0.04 | |||||
| EV-to-EBIT | -0.25 | |||||
| EV-to-EBITDA | -0.32 | |||||
| EV-to-Revenue | 0.74 | |||||
| EV-to-FCF | -0.33 | |||||
| Earnings Yield (Greenblatt) % | -400 | |||||
| FCF Yield % | -1473.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NightHawk Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.044 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 6.72917 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 6.72917 - 6.72917 | ||
| Shares Outstanding (Mil) | 26.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NightHawk Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NightHawk Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NightHawk Biosciences Inc Frequently Asked Questions
What is NightHawk Biosciences Inc(LTS:0A4E)'s stock price today?
The current price of LTS:0A4E is $6.73. The 52 week high of LTS:0A4E is $6.73 and 52 week low is $6.73.
When is next earnings date of NightHawk Biosciences Inc(LTS:0A4E)?
The next earnings date of NightHawk Biosciences Inc(LTS:0A4E) is 2025-02-28 Est..
Does NightHawk Biosciences Inc(LTS:0A4E) pay dividends? If so, how much?
NightHawk Biosciences Inc(LTS:0A4E) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers